Menstrual changes after COVID-19 vaccination and/or SARS-CoV-2 infection and their demographic, mood, and lifestyle determinants in Arab women of childbearing age, 2021.
Menstrual changes after COVID-19 vaccination and/or SARS-CoV-2 infection and their demographic, mood, and lifestyle determinants in Arab women of childbearing age, 2021.
复制标题
DOI:
10.3389/frph.2022.927211
复制
发表时间:
2022
影响因子:
--
通讯作者:
Ramadan, Mohamed Sh
中科院分区:
文献类型:
--
作者:
Amer, Ahmed A.;Amer, Samar A.;Alrufaidi, Khaled Masoud;Abd-Elatif, Eman Elsayed;Alafandi, Bana Zuhair;Yousif, Dalia Abdelmonaim;Armi, Nadia Toukah;Alkhalaf, Atheer Abdulaziz;Shah, Jaffer;Ramadan, Mohamed Sh
By September 2, 2021, over 30,000 COVID-19-vaccinated females had reported menstrual changes to the MHRA's Yellow Card surveillance system. As a result, the National Institutes of Health (NIH) is urging researchers to investigate the COVID-19 vaccine's effects on menstruation. Therefore, this study was conducted to explore the menstrual changes after COVID-19 vaccination and/or SARS-CoV-2 infection and their interrelations with demographic, mood, and lifestyle factors in Arab women of childbearing age (CBA). A cross-sectional study was conducted during October 2021 using an Arabic validated and self-administrated questionnaire. In total, 1,254 Women of CBA in the Arabic Population (15–50 y) with regular menstrual cycles were randomly selected from five countries (Saudi Arabia, Egypt, Syria, Libya, and Sudan). The mean (SD) age of the 1,254 studied females was 29.6 (8.5) years old. In total, 634 (50%) were married, 1,104 (88.0%) had a University education or above, 1,064 (84.4%) lived in urban areas, and 573 (45.7%) had normal body weight. Moreover, 524 (41.8%) were COVID-19 cases and 98 women (18.7%) reported menstrual changes (MCs). The 1,044 (83.5%) vaccinated females reported 418 (38.5%) MCs after being vaccinated, and these MCs resolved in 194 women (55.1%) after more than 9 months. Statistically significant relationships were observed between the reported MCs and the following variables: age, marital status, level of education, nationality, residence, and BMI. MCs were reported at 293(80.6) after the 2nd dose, and were mainly reported after 482 (46.1) Pfizer, 254 (24.3) Astrazenica, and 92 (8.8) Senopharm. MCs among women of CBA after COVID-19 infection and vaccination are prevalent and complex problems, and had many determinates.
登录
查看更多内容
影响因子:
6.1
作者:
Bentov, Y.;Beharier, O.;Klement, A. Hersko
通讯作者:
Klement, A. Hersko
影响因子:
168.9
作者:
Huang, Chaolin;Wang, Yeming;Cao, Bin
通讯作者:
Cao, Bin
DOI:
10.1038/s41577-021-00525-y
发表时间:
2021-04
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
Male V
通讯作者:
Male V
影响因子:
120.7
作者:
Goldshtein, Inbal;Nevo, Daniel;Segal, Yaakov
通讯作者:
Segal, Yaakov
影响因子:
7.2
作者:
Edelman A;Boniface ER;Benhar E;Han L;Matteson KA;Favaro C;Pearson JT;Darney BG
通讯作者:
Darney BG